Skip to main content
Clinical Trials/NCT03043612
NCT03043612
Completed
N/A

Cook Ureteral Stent Study

Cook Group Incorporated1 site in 1 country56 target enrollmentJune 10, 2015
ConditionsUrolithiasis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Urolithiasis
Sponsor
Cook Group Incorporated
Enrollment
56
Locations
1
Primary Endpoint
Patient-reported body pain score
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the feasibility of the Cook Ureteral Stent to reduce post-stent placement pain and urinary symptoms in patients following ureteroscopy for urolithiasis.

Registry
clinicaltrials.gov
Start Date
June 10, 2015
End Date
June 30, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient is undergoing ureteroscopy for urolithiasis in which temporary ureteral stenting is indicated

Exclusion Criteria

  • Patient is unwilling or unable to sign and date the informed consent
  • Patient is unwilling to comply with the follow-up study schedule
  • Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study
  • Patient is currently taking anti-cholinergic or other anti-spasm medications
  • Patient is currently taking sildenafil, tadalafil, or vardenafil
  • Patient has a known sensitivity to alpha-blocker medications
  • Patient is currently undergoing chemotherapy or radiation therapy
  • Patient has an active urinary tract infection
  • Patient is in chronic renal failure, on hemodialysis, or on chronic peritoneal dialysis
  • Patient requires bilateral shock wave lithotripsy, bilateral stents, or has bilateral symptomatic kidney stones

Outcomes

Primary Outcomes

Patient-reported body pain score

Time Frame: 7-days post stent placement

Comparing the patient-reported body pain score from the USSQ 1 survey between the two study arms

Study Sites (1)

Loading locations...

Similar Trials